{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:31:57Z","timestamp":1761093117317,"version":"build-2065373602"},"reference-count":33,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004897","name":"Pennsylvania Department of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.urolonc.2020.04.010","type":"journal-article","created":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T22:15:40Z","timestamp":1589235340000},"page":"737.e17-737.e23","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Association between metabolic syndrome and recurrence of nonmuscle-invasive bladder cancer in older adults"],"prefix":"10.1016","volume":"38","author":[{"given":"Tullika","family":"Garg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda J.","family":"Young","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maureen","family":"O'Keeffe-Rosetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmit K.","family":"McMullen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew E.","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terrence E.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. Lester","family":"Kirchner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2020.04.010_bib0001","first-page":"252","article-title":"Cancer treatment and survivorship statistics, 2014","volume":"64","author":"DeSantis","year":"2014","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.urolonc.2020.04.010_bib0002","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1158\/1055-9965.EPI-16-0133","article-title":"Anticipating the \u201csilver tsunami\u201d: prevalence trajectories and comorbidity burden among older cancer survivors in the United States","volume":"25","author":"Bluethmann","year":"2016","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.urolonc.2020.04.010_bib0003","unstructured":"National Comprehensive Cancer Network. Older adult oncology (version 1.2019). https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/senior.pdf. Accessed December 31, 2019."},{"key":"10.1016\/j.urolonc.2020.04.010_bib0004","unstructured":"American Cancer Society: Cancer facts & figures 2018. https:\/\/www.cancer.org\/content\/dam\/cancer-org\/research\/cancer-facts-and-statistics\/annual-cancer-facts-and-figures\/2018\/cancer-facts-and-figures-2018.pdf. Accessed December 31, 2019"},{"key":"10.1016\/j.urolonc.2020.04.010_bib0005","first-page":"7","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.urolonc.2020.04.010_bib0006","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.juro.2016.06.049","article-title":"Diagnosis and treatment of non-muscle invasive bladder cancer: AUA\/SUO Guideline","volume":"196","author":"Chang","year":"2016","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2020.04.010_bib0007","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.juro.2017.08.005","article-title":"Burden of multiple chronic conditions among patients with urological cancer","volume":"199","author":"Garg","year":"2018","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2020.04.010_bib0008","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1001\/jama.287.3.356","article-title":"Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey","volume":"287","author":"Ford","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.urolonc.2020.04.010_bib0009","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.urolonc.2020.04.010_bib0010","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1002\/ijc.25521","article-title":"Metabolic syndrome and risk of bladder cancer: prospective cohort study in the metabolic syndrome and cancer project (Me-Can)","volume":"128","author":"H\u00e4ggstr\u00f6m","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1016\/j.urolonc.2020.04.010_bib0011","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.urpr.2017.02.012","article-title":"Association between metabolic syndrome and recurrence of nonmuscle invasive bladder cancer following bacillus Calmette-Gu\u00e9rintreatment","volume":"5","author":"Lenis","year":"2018","journal-title":"Urol Pract"},{"key":"10.1016\/j.urolonc.2020.04.010_bib0012","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.1002\/cncr.31705","article-title":"Association between treatment of superficial bladder cancer and 10year mortality in older adults with multiple chronic conditions","volume":"124","author":"Garg","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2020.04.010_bib0013","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am StatAssoc"},{"year":"2017","series-title":"Multiple chronic conditions in the United States","author":"Buttorff","key":"10.1016\/j.urolonc.2020.04.010_bib0014"},{"key":"10.1016\/j.urolonc.2020.04.010_bib0015","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/iju.12644","article-title":"Association between metabolic syndrome, obesity, diabetes mellitus and oncological outcomes of bladder cancer: a systematic review","volume":"22","author":"Cantiello","year":"2014","journal-title":"Int J Urol"},{"key":"10.1016\/j.urolonc.2020.04.010_bib0016","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1200\/JCO.2008.20.8983","article-title":"Future of cancer incidence in the United States: burdens upon an aging, changing nation","volume":"27","author":"Smith","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2020.04.010_bib0017","doi-asserted-by":"crossref","first-page":"911","DOI":"10.14740\/jocmr3617w","article-title":"Comparison of comorbid conditions between cancer survivors and age-matched patients without cancer","volume":"10","author":"Roy","year":"2018","journal-title":"J Clin Med Res"},{"key":"10.1016\/j.urolonc.2020.04.010_bib0018","first-page":"484","article-title":"Adiposity and cancer risk: new mechanistic insights from epidemiology","volume":"15","author":"Renehan","year":"2015","journal-title":"Nat Pub Group"},{"key":"10.1016\/j.urolonc.2020.04.010_bib0019","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.15585\/mmwr.mm6639e1","article-title":"Vital signs: trends in incidence of cancers associated with overweight and obesity\u2013United States, 2005-2014","volume":"66","author":"Steele","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.urolonc.2020.04.010_bib0020","first-page":"51","article-title":"Obesity in the elderly: more complicated than you think","volume":"81","author":"Cetin","year":"2014","journal-title":"CleveClin J Med"},{"key":"10.1016\/j.urolonc.2020.04.010_bib0021","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1093\/jnci\/djt310","article-title":"An epidemiologic and genomic investigation into the obesity paradox in renal cell carcinoma","volume":"105","author":"Hakimi","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.urolonc.2020.04.010_bib0022","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S1470-2045(18)30078-0","article-title":"Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis","volume":"19","author":"McQuade","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.urolonc.2020.04.010_bib0023","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/ajh.23462","article-title":"Association between baseline body mass index and overall survival among patients over age 60 with acute myeloid leukemia","volume":"88","author":"Brunner","year":"2013","journal-title":"Am J Hematol"},{"key":"10.1016\/j.urolonc.2020.04.010_bib0024","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1016\/j.clnu.2018.12.011","article-title":"Obesity survival paradox in cancer patients: results from the Physical Frailty in older adult cancer patients (PF-EC) study","volume":"38","author":"Pamoukdjian","year":"2019","journal-title":"Clin Nutr"},{"key":"10.1016\/j.urolonc.2020.04.010_bib0025","first-page":"56","article-title":"The obesity paradox in cancer: a review","volume":"18","author":"Lennon","year":"2016","journal-title":"CurrOncol Rep"},{"key":"10.1016\/j.urolonc.2020.04.010_bib0026","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/bju.13399","article-title":"Impact of frailty on complications in patients undergoing common urological procedures: a study from the American College of Surgeons National Surgical Quality Improvement database","volume":"117","author":"Suskind","year":"2016","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2020.04.010_bib0027","article-title":"Association of preoperative patient frailty and operative stress with postoperative mortality","author":"Shinall","year":"2019","journal-title":"JAMA Surg"},{"key":"10.1016\/j.urolonc.2020.04.010_bib0028","first-page":"480","article-title":"Obesity is associated with worse outcomes in patients with T1 high grade urothelial carcinoma of the bladder","volume":"190","author":"Kluth","year":"2013","journal-title":"JURO"},{"key":"10.1016\/j.urolonc.2020.04.010_bib0029","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/cncr.28394","article-title":"Body mass and smoking are modifiable risk factors for recurrent bladder cancer","volume":"120","author":"Wyszynski","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2020.04.010_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5489\/cuaj.4870","article-title":"Impact of oral hypoglycemicagents on mortality among diabetic patients with non-muscle-invasive bladder cancer: a population-based analysis","volume":"12","author":"Richard","year":"2018","journal-title":"CUAJ"},{"key":"10.1016\/j.urolonc.2020.04.010_bib0031","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1111\/bju.12448","article-title":"Association of diabetes mellitus and metformin use with oncological outcomes of patients with non-muscle-invasive bladder cancer","volume":"112","author":"Rieken","year":"2013","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2020.04.010_bib0032","doi-asserted-by":"crossref","first-page":"210","DOI":"10.5414\/CP202670","article-title":"Association between pioglitazone use and the risk of bladder cancer among subjects with diabetes mellitus: a dose-response meta-analysis","volume":"55","author":"Li","year":"2017","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.urolonc.2020.04.010_bib0033","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/bcp.12306","article-title":"Thiazolidinediones and associated risk of bladder cancer: a systematic review and meta-analysis","volume":"78","author":"Turner","year":"2014","journal-title":"Br J Clin Pharmacol"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143920301502?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143920301502?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:19:19Z","timestamp":1761041959000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143920301502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":33,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S1078143920301502"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2020.04.010","relation":{},"ISSN":["1078-1439"],"issn-type":[{"type":"print","value":"1078-1439"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between metabolic syndrome and recurrence of nonmuscle-invasive bladder cancer in older adults","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2020.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}